⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18028045 | 0.82 | — | — | |
| SCHEMBL16629083 | 0.78 | — | — | |
| SCHEMBL17274222 | 0.72 | — | — | |
| SCHEMBL15028484 | 0.70 | BMP1 (0.30) | — | |
| SCHEMBL18028046 | 0.69 | NEU4 (0.32) | — | |
| SCHEMBL13881437 | 0.69 | NEU4 (0.32) | — | |
| SCHEMBL16684312 | 0.68 | — | — | |
| SCHEMBL25790219 | 0.68 | NEU2 (0.34) | — | |
| SCHEMBL16901679 | 0.66 | — | — | |
| SCHEMBL17973547 | 0.64 | ACE (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015173341-A1 | DOSAGE PRINCIPLE FOR ANTI-CANCER FURAZANYLBENZIMIDAZOLES | BASILEA PHARMACEUTICA AG (CH) | 2015-11-19 | — | — | WO | disclosed |